• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过选择性靶向脂质代谢来革新针对结核分枝杆菌感染的控制策略。

Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism.

机构信息

Department of Microbiology, Institute for Immunology and Immunological Disease, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Cell Mol Life Sci. 2023 Sep 14;80(10):291. doi: 10.1007/s00018-023-04914-5.

DOI:10.1007/s00018-023-04914-5
PMID:37704889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11072447/
Abstract

Lipid species play a critical role in the growth and virulence expression of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). During Mtb infection, foamy macrophages accumulate lipids in granulomas, providing metabolic adaptation and survival strategies for Mtb against multiple stresses. Host-derived lipid species, including triacylglycerol and cholesterol, can also contribute to the development of drug-tolerant Mtb, leading to reduced efficacy of antibiotics targeting the bacterial cell wall or transcription. Transcriptional and metabolic analyses indicate that lipid metabolism-associated factors of Mtb are highly regulated by antibiotics and ultimately affect treatment outcomes. Despite the well-known association between major antibiotics and lipid metabolites in TB treatment, a comprehensive understanding of how altered lipid metabolites in both host and Mtb influence treatment outcomes in a drug-specific manner is necessary to overcome drug tolerance. The current review explores the controversies and correlations between lipids and drug efficacy in various Mtb infection models and proposes novel approaches to enhance the efficacy of anti-TB drugs. Moreover, the review provides insights into the efficacious control of Mtb infection by elucidating the impact of lipids on drug efficacy. This review aims to improve the effectiveness of current anti-TB drugs and facilitate the development of innovative therapeutic strategies against Mtb infection by making reverse use of Mtb-favoring lipid species.

摘要

脂质种类在结核分枝杆菌(Mtb)的生长和毒力表达中起着关键作用,Mtb 是结核病(TB)的病原体。在 Mtb 感染期间,泡沫状巨噬细胞在肉芽肿中积累脂质,为 Mtb 提供代谢适应和生存策略,以应对多种压力。宿主来源的脂质种类,包括三酰甘油和胆固醇,也可以促进耐药 Mtb 的发展,导致针对细菌细胞壁或转录的抗生素疗效降低。转录和代谢分析表明,Mtb 的脂质代谢相关因素受抗生素的高度调控,最终影响治疗结果。尽管在 TB 治疗中主要抗生素和脂质代谢物之间存在众所周知的关联,但全面了解宿主和 Mtb 中脂质代谢物的变化如何以特定药物的方式影响治疗结果,对于克服药物耐受性是必要的。本综述探讨了不同 Mtb 感染模型中脂质与药物疗效之间的争议和相关性,并提出了增强抗结核药物疗效的新方法。此外,该综述通过阐明脂质对药物疗效的影响,为有效控制 Mtb 感染提供了新的思路。本综述旨在通过反向利用有利于 Mtb 的脂质种类来提高现有抗结核药物的疗效,并促进针对 Mtb 感染的创新治疗策略的发展。

相似文献

1
Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism.通过选择性靶向脂质代谢来革新针对结核分枝杆菌感染的控制策略。
Cell Mol Life Sci. 2023 Sep 14;80(10):291. doi: 10.1007/s00018-023-04914-5.
2
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
3
Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?理解抗生素与宿主免疫系统的相互作用:我们如何提高现有药物的抗分枝杆菌活性,以更好地控制结核病?
Front Immunol. 2021 Jun 28;12:703060. doi: 10.3389/fimmu.2021.703060. eCollection 2021.
4
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.一种新型工具,可鉴定干酪样物中耐药物结核分枝杆菌的脆弱靶标中的杀菌化合物。
mBio. 2023 Apr 25;14(2):e0059823. doi: 10.1128/mbio.00598-23. Epub 2023 Apr 5.
5
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.针对结核分枝杆菌肉芽肿的宿主导向治疗:综述
Semin Immunopathol. 2016 Mar;38(2):167-83. doi: 10.1007/s00281-015-0537-x. Epub 2015 Oct 28.
6
Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.利用生物学洞察力加速结核病药物发现。
Acc Chem Res. 2019 Aug 20;52(8):2340-2348. doi: 10.1021/acs.accounts.9b00275. Epub 2019 Jul 30.
7
The impact of on the macrophage cholesterol metabolism pathway.对巨噬细胞胆固醇代谢途径的影响。
Front Immunol. 2024 May 30;15:1402024. doi: 10.3389/fimmu.2024.1402024. eCollection 2024.
8
Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy.感染驱动的泡沫状巨噬细胞及其作为宿主导向治疗靶点在结核病控制中的意义。
Front Immunol. 2020 May 12;11:910. doi: 10.3389/fimmu.2020.00910. eCollection 2020.
9
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
10
Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in .中心碳代谢重编程作为产生药物耐受性和耐药性的机制。
Front Cell Infect Microbiol. 2022 Aug 22;12:958240. doi: 10.3389/fcimb.2022.958240. eCollection 2022.

引用本文的文献

1
Feature selection and aggregation for antibiotic resistance GWAS in : a comparative study.抗生素耐药性全基因组关联研究中的特征选择与聚合:一项比较研究
Front Microbiol. 2025 Jun 18;16:1586476. doi: 10.3389/fmicb.2025.1586476. eCollection 2025.
2
Trimming the fat: a brief review of lipids at the host-pathogen interface.去除脂肪:宿主-病原体界面脂质的简要综述
Infect Immun. 2025 Jul 8;93(7):e0050624. doi: 10.1128/iai.00506-24. Epub 2025 Jun 13.
3
Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of .对脂质利用的仔细研究破坏了临床分离株中两性霉素B的反应性。 (注:原文中“of”后面内容缺失)
Elife. 2025 May 27;14:RP102857. doi: 10.7554/eLife.102857.
4
Development and Validation of Early Alert Model for Diabetes Mellitus-Tuberculosis Comorbidity.糖尿病合并结核病早期预警模型的开发与验证
Microorganisms. 2025 Apr 16;13(4):919. doi: 10.3390/microorganisms13040919.
5
Mendelian randomization study of lipid species reveals causal relationship with syphilis.脂质种类的孟德尔随机化研究揭示了与梅毒的因果关系。
AMB Express. 2025 Apr 9;15(1):63. doi: 10.1186/s13568-025-01873-x.
6
Synthesis of cationic -acylated thiazolidine for selective activity against Gram-positive bacteria and evaluation of -acylation's role in membrane-disrupting activity.用于对革兰氏阳性菌具有选择性活性的阳离子酰化噻唑烷的合成及酰化在膜破坏活性中的作用评估。
RSC Med Chem. 2024 Oct 21. doi: 10.1039/d4md00626g.
7
From pathogenesis to antigens: the key to shaping the future of TB vaccines.从发病机制到抗原:塑造结核病疫苗未来的关键。
Front Immunol. 2024 Jul 23;15:1440935. doi: 10.3389/fimmu.2024.1440935. eCollection 2024.
8
PPARdelta: A key modulator in the pathogenesis of diabetes mellitus and co-morbidity.过氧化物酶体增殖物激活受体δ:糖尿病及其合并症发病机制中的关键调节因子。
iScience. 2024 May 22;27(7):110046. doi: 10.1016/j.isci.2024.110046. eCollection 2024 Jul 19.
9
The impact of on the macrophage cholesterol metabolism pathway.对巨噬细胞胆固醇代谢途径的影响。
Front Immunol. 2024 May 30;15:1402024. doi: 10.3389/fimmu.2024.1402024. eCollection 2024.
10
Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated .氟伐他汀可将人巨噬细胞转化为泡沫细胞,并增强对灭活 的炎症反应。
Cells. 2024 Mar 18;13(6):536. doi: 10.3390/cells13060536.

本文引用的文献

1
The fat is in the lysosome: how Mycobacterium tuberculosis tricks macrophages into storing lipids.脂肪在溶酶体中:结核分枝杆菌如何欺骗巨噬细胞储存脂质。
J Clin Invest. 2023 Mar 15;133(6):e168366. doi: 10.1172/JCI168366.
2
A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages.结核分枝杆菌萜核苷诱导泡沫巨噬细胞溶酶体脂质蓄积。
J Clin Invest. 2023 Mar 15;133(6):e161944. doi: 10.1172/JCI161944.
3
Atorvastatin Potentially Reduces Mycobacterial Severity through Its Action on Lipoarabinomannan and Drug Permeability in Granulomas.阿托伐他汀可能通过其对脂阿拉伯甘露聚糖和肉芽肿中药物渗透性的作用来降低分枝杆菌的严重程度。
Microbiol Spectr. 2023 Jan 31;11(2):e0319722. doi: 10.1128/spectrum.03197-22.
4
Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in by the Novel Drug Candidate GSK2556286.新型药物候选物 GSK2556286 通过环磷酸腺苷抑制 中的胆固醇分解代谢。
Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0129422. doi: 10.1128/aac.01294-22. Epub 2023 Jan 5.
5
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective with the Potential To Shorten Tuberculosis Treatment.GSK2556286 是一种新型抗结核候选药物,具有缩短结核病治疗疗程的潜力。
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0013222. doi: 10.1128/aac.00132-22. Epub 2022 May 24.
6
Host-directed anti-mycobacterial activity of colchicine, an anti-gout drug, via strengthened host innate resistance reinforced by the IL-1β/PGE axis.秋水仙碱(一种治疗痛风的药物)通过增强 IL-1β/PGE 轴增强的宿主固有抵抗力,发挥宿主定向抗分枝杆菌活性。
Br J Pharmacol. 2022 Aug;179(15):3951-3969. doi: 10.1111/bph.15838. Epub 2022 Apr 7.
7
Clinical Factors Associated with Cavitary Tuberculosis and Its Treatment Outcomes.与空洞型肺结核及其治疗结果相关的临床因素。
J Pers Med. 2021 Oct 25;11(11):1081. doi: 10.3390/jpm11111081.
8
Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis.影像学和功能证据表明结核病支气管播散:一项观察性分析。
Lancet Microbe. 2021 Oct;2(10):e518-e526. doi: 10.1016/S2666-5247(21)00058-6.
9
Host lipidome and tuberculosis treatment failure.宿主脂质组与结核病治疗失败。
Eur Respir J. 2022 Jan 6;59(1). doi: 10.1183/13993003.04532-2020. Print 2022 Jan.
10
Synthetic molecules as DprE1 inhibitors: A patent review.作为 DprE1 抑制剂的合成分子:专利审查。
Expert Opin Ther Pat. 2021 Aug;31(8):759-772. doi: 10.1080/13543776.2021.1902990. Epub 2021 Apr 13.